Compare Nutrien Ltd (NTR) vs Synchrony Financial (SYF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutrien Ltd vs Synchrony Financial — how do they compare? Nutrien Ltd trades at $67.48 (market cap $33.31B), while Synchrony Financial trades at $72.8 (market cap $23.99B). The key difference: Nutrien Ltd is the larger of the two by market cap, and Nutrien Ltd pays the higher dividend (3.15%). Which is the better fit depends on your goals — on Pluang, investors hold Nutrien Ltd for 59 Days and Synchrony Financial for 29 Days on average.
| NTR | SYF | |
|---|---|---|
Market Cap | $33.31B | $23.99B |
Volume | 1,330,729 | 3,813,027 |
Sector | Basic Materials | Financials |
52-Week High | $83.94 | $88.47 |
52-Week Low | $53.64 | $63.78 |
Typical Hold Time | 59 Days | 29 Days |
Enterprise Value | $45.11B | $24.23B |
Dividend Yield | 3.15% | 1.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTR trades at $67.48, down 3.56% over 24 hours, with technical indicators showing a bearish trend. The company reported mixed quarterly earnings, missing Q4 2025 and Q2 2026 EPS estimates but beating in Q1 2026. Financials show a net income margin of 8.44% for 2025, with revenue of $26.89B, while recent news highlights industry headwinds from potential U.S. potash deals with Belarus.
The outlook is cautious; analyst consensus is a Moderate Buy with a $76.14 price target, but near-term risks include volatile fertilizer prices and competitive pressures. Long-term demand for agricultural inputs supports fundamentals, yet investors face cyclical earnings and margin compression risks amid macroeconomic uncertainty.
Synchrony Financial (SYF) trades at $72.80, up 1.21% on the day, with a bullish technical signal despite some bearish moving average indicators. The company demonstrates strong fundamentals with a low P/E ratio of 7.56 and robust profitability, including a 23.4% net income margin and 22.23% ROE. Recent earnings have consistently beaten estimates, and positive news includes a partnership with OpenAI and expansion of its CareCredit platform.
The outlook is positive, supported by strong analyst consensus with a $87.58 price target and a 'Moderate Buy' rating. Key opportunities include attractive valuation and strategic partnerships, while risks involve increased investing outflows leading to negative net cash flow in 2026 and potential economic sensitivity affecting credit performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →About Synchrony Financial
Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →
